QUAD - About the company
QUAD is an unfunded company based in Seoul (South Korea), founded in 2010. It operates as an Investment management firm. QUAD has not raised any funding yet.
Company Details
- Website
- www.quadim.com/
- Email ID
- *****@quadim.com
Key Metrics
Founded Year
2010
Location
Seoul, South Korea
Stage
Unfunded
Employee Count
27 as on May 31, 2026
Investment & Acquisitions
Similar Companies
Sign up to download QUAD's company profile
QUAD's funding and investors
QUAD has not raised any funding rounds yet.
QUAD's founders and board of directors
Founder? Claim ProfileQUAD's employee count trend
QUAD has 27 employees as of May 26. Here is QUAD's employee count trend over the years:
Uncover QUAD's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
QUAD's Investments and acquisitions
QUAD has not made any acquisitions yet. QUAD has made 23 investments.Here is the list of latest three $investments:
Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Aug 19, 2026 | Investments | 2019 | Pittsburgh (United States) | |
Jun 05, 2026 | Investments | 2019 | Seoul (South Korea) | |
Mar 31, 2026 | Investments | 2016 | Seoul (South Korea) |
Want to know more about where corporates are investing? Sign up today!See all investments by QUAD
Reports related to QUAD
Here is the latest report on QUAD's sector:
News related to QUAD
Filter this listMedia has covered QUAD for 1 event in last 1 year.
•
KaliVir Immunotherapeutics Raises $14M in Series A Extension FundingFinSMEs•Aug 19, 2026•QUAD, KaliVir Immunotherapeutics, Nextrans, Company K Partners and 2 others
•
Illimis secures funding for GAIA-based Alzheimer’s therapeutics
Pharmaceutical Technology•Jul 14, 2025•Illimis Therapeutics, Woori Ventures Partners, DSC Investment, Korean Development Bank and 3 others
•
Illimis Therapeutics Secures $42M Series B Funding for Drug DevelopmentPR Newswire•Jul 14, 2025•LB Investment, Daily Partners, GS Ventures, Company K Partners and 12 others
•
Ubix Therapeutics draws ₩25.7 million pre-IPO fundingKBR•Dec 24, 2024•Uvic Steratics, Solidus Capital, Atinum Investment, KB Investment and 4 others
•
AI drug developer Aigen Sciences raises ₩12B series ABioWorld•Oct 30, 2024•AIGEN Sciences, Partners Capital, QUAD, Medytox Venture and 3 others
•
Avelos therapeutics announces krw 17 billion series b funding round, surpassing krw 30 billion total raisedPR Newswire•May 29, 2024•Avelos Therapeutics, Stassets Investment, LSK investment, Medytox Venture and 7 others
•
HoneyNaps secures a $11.6 million Series B investment, becoming the No. 1 ranked A.I Sleep Technology CompanyAsiaone•May 24, 2024•HoneyNaps, Industrial Bank of Korea, Hi Investment, QUAD and 1 other
•
•
Vedanta Biosciences Raises $106.5M in FundingFinSMEs•Apr 25, 2023•Vedanta Biosciences, AXA Investment Managers, AMR Action Fund, Gates and 14 others
•
Korean restaurant startup GFFG raises $23 million in Series A roundKedglobal•Dec 05, 2022•Good Food for Good, Altos Ventures Management, QUAD
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about QUAD
Explore our recently published companies
- Marketing Agency - Deptford based, 2020 founded, Unfunded company
- Aquiyel Services - Houston based, 2020 founded, Public company
- B2clogin.com - 2017 founded, Unfunded company
- Compose Finance - Warsaw based, 2024 founded, Unfunded company
- Bubbls - United Kingdom based, Unfunded company
- TedhiMedhi Family - India based, Unfunded company
